©2013 Baishideng.
Figure 9 The case of primary megakaryocytic and granulocytic myeloproliferation in Figure 7, who presented in 1995 with microvascular circulation disturbances treated with hydroxyurea for 11 years complicated by mild anemia at platelet counts of 600 × mm3/L after 10 years of hydroxyurea (HU) for 10 years (1996-2006).
-
Citation: Michiels JJ, Berneman Z, Schroyens W, Lam KH, De Raeve H. PVSG and WHO
vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms. World J Hematol 2013; 2(3): 71-88 - URL: https://www.wjgnet.com/2218-6204/full/v2/i3/71.htm
- DOI: https://dx.doi.org/10.5315/wjh.v2.i3.71